Paris, France and Camberley, UK – 28 February 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to provide an update regarding the novel coronavirus (COVID-19) test developed by Primerdesign, its molecular diagnostics division, and announces it has signed a major distribution agreement in Asia and an original equipment manufacturer (OEM) agreement with a US healthcare group.
http://novacyt.com/wp-content/uploads/2020/02/Novacyt-Covid-19-test-update-ENGLISH-28.02.20.pdf